Axxin: World Leading Biomedical Diagnostic Instrumentation
Take the cost and complexity out of point of care diagnostics and near patient applications
Axxin
Axxin provides platforms and diagnostic products for biomedical applications that bridge the gap from research to market with world leading innovation, capability, and cost effectiveness.
With extensive experience in instrument design, industrial design, and sensor technologies, Axxin develops innovative solutions for molecular and lateral flow diagnostics.
Axxin was founded in 2007 and has since established itself as an early leader in commercialising diagnostic delivery systems in partnership with leading biomedical and pharmaceutical companies.
AXXIN IS ISO 13485 CERTIFIED
Core Competencies
Upcoming Events
2025 Precision Med TRI-CON
San Diego, CA 11th - 13th March 2025
For 3 decades, the Precision Med TRI-CON has served as the leading international meeting place for the diagnostics and precision medicine community. Join over a thousand international thought leaders to discuss the latest research, technologies, innovation and business models in implementing precision medicine, biomarkers and companion diagnostics, genomic medicine, and artificial intelligence; innovation and market access strategies for at-home diagnostics, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology, including multi-cancer early detection and minimal residual disease testing. Come and meet Axxin's Nathan Butlin, VP Strategy & Alliances, and Axxin CEO, Andrew Lysikatos at booth 303. Held at the Town and Country Resort, 500 Hotel Circle North, San Diego, CA 92108. Contact: sales@axxin.com